Charles Cazabon Overview
- Firm
- BDC Capital
- Primary Position
-
Managing Partner...
- Primary Industry
-
Healthcare
- Active Board Seats
-
1
- Med. Deal Size
-
Charles Cazabon General Information
Biography
Mr. Charles Cazabon served as a Board Member at viDA Therapeutics. Mr. Cazabon served as Managing Partner at BDC Capital. Before joining BDC in 2001, he served as Vice President at one of the Caisse de dépôt et placement du Québec's investment subsidiaries, where he managed a team that provided venture capital, expansion, and acquisition services for Quebec-based businesses. Previously, he worked in PE and VC firms in Montreal and Toronto, with an M&A boutique in Montreal, and in commercial lending in Southern Ontario. He has served on numerous public and private company boards and is a former President and member of the Board of Réseau Capital, the Quebec Venture Capital and Private Equity Association. He currently sits on the Board of Directors of five companies. Mr. Cazabon holds an MBA from the University of Western Ontario, a Master of Science in Biology from Laurentian University, and an Honours Bachelor of Science from the University of Waterloo.
Contact Information
Address
- 887 Great Northern Way
- Unit 125
- Vancouver, British Columbia V5T 4T5
- Canada
Charles Cazabon Board Seats (1)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
viDA Therapeutics | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Vancouver, Canada |
Charles Cazabon Lead Partner on Deals (2)
Charles Cazabon has been the lead partner on 2 deals. Their latest deal was with viDA Therapeutics, a drug discovery company. The deal was made for on 24-Apr-2013.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
viDA Therapeutics | 24-Apr-2013 | Seed Round | Completed | Drug Discovery | Vancouver, Canada | |
NATRIX Separations | 09-Aug-2010 | Completed | Biotechnology | Burlington, Canada |
Charles Cazabon Network (44)
Board Members (20)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Gosse Bruinsma MD | viDA Therapeutics | Self | Vancouver, Canada | |
Dominique Belanger | viDA Therapeutics | BDC Capital | Vancouver, Canada | |
viDA Therapeutics | Self | Vancouver, Canada | ||
NeurAxon Pharma | Business Development Bank of Canada | Mississauga, Canada | ||
NATRIX Separations | Self | Burlington, Canada |
Portfolio Executives (17)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Vicki Morgan | viDA Therapeutics | Vice President of Business Development | 24-Apr-2013 | Vancouver, Canada |
Robert Ryan Ph.D | viDA Therapeutics | Chairman | 24-Apr-2013 | Vancouver, Canada |
viDA Therapeutics | Co-Founder & Chief Scientific Officer | 24-Apr-2013 | Vancouver, Canada | |
viDA Therapeutics | Co-Founder, President, Chief Executive Officer and Board Member | 24-Apr-2013 | Vancouver, Canada | |
viDA Therapeutics | Chief Operating Officer & Advisor | 24-Apr-2013 | Vancouver, Canada |
Fund Team Members (7)
Name | Investor | Fund | Fund Location |
---|---|---|---|
Dominique Belanger | BDC Capital | BDC Diversified Portfolio | Montreal, Canada |
Nazmin Alani | BDC Capital | BDC Diversified Portfolio | Montreal, Canada |
BDC Capital | Montreal, Canada | ||
BDC Capital | Montreal, Canada | ||
BDC Capital | Montreal, Canada |
Charles Cazabon Affiliated Funds (1)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
BDC Diversified Portfolio | BDC Capital | Venture Capital - Later Stage | Fully Invested | 2011 |
Charles Cazabon FAQs
-
Who is Charles Cazabon?
Mr. Charles Cazabon served as a Board Member at viDA Therapeutics.
-
How much does Charles Cazabon typically invest?
Charles Cazabon's median deal size is
. -
What is Charles Cazabon’s main position?
Charles Cazabon’s primary position is Managing Partner, Co-Investments.
-
How many active board seats does Charles Cazabon hold?
Charles Cazabon holds a board seat in viDA Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »